PharmEasy gets $300 million booster shot for Thyrocare deal
ETtech Exclusive: PharmEasy gets $300 million booster shot for Thyrocare deal SECTIONS Last Updated: Jun 28, 2021, 08:08 AM IST Share Synopsis PharmEasy has raised $300 million more, bringing the total funding received by the online pharmacy since April to $650 million, most of which will be used to fund its ongoing acquisition of diagnostics chain Thyrocare. ETtech The Pharmeasy-Thyrocare deal will allow the online pharmacy to offer four key elements of healthcare—information, consult, test and treatment—at a time when online adoption is growing due to the pandemic. (Illustration: Rahul ...